{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T13:16:51Z","timestamp":1756991811265},"reference-count":16,"publisher":"Royal College of Psychiatrists","issue":"3","license":[{"start":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T00:00:00Z","timestamp":1517184000000},"content-version":"unspecified","delay-in-days":12022,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Psychiatry"],"published-print":{"date-parts":[[1985,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The neuroleptic malignant syndrome (NMS) is an idiosyncratic reaction to neuroleptic drugs, made up of hyperthermia, muscular rigidity, disturbance of level of consciousness and autonomic dysfunction. It is potentially lethal and should be kept in mind whilst using anti-psychotic drugs; as most patients treated by them require further anti-psychotic treatment, the clinician faces the problem of treating those patients after a NMS episode, yet reports in the literature have generally neglected the problem of late management. A patient suffering from a psychosis and NMS is presented, and a rationale for management offered.<\/jats:p>","DOI":"10.1192\/bjp.146.3.317","type":"journal-article","created":{"date-parts":[[2008,8,12]],"date-time":"2008-08-12T23:20:52Z","timestamp":1218583252000},"page":"317-318","source":"Crossref","is-referenced-by-count":18,"title":["The Aftercare of the Patient with the Neuroleptic Malignant Syndrome"],"prefix":"10.1192","volume":"146","author":[{"given":"Dov","family":"Aizenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arieh","family":"Shalev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanan","family":"Munitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"170","published-online":{"date-parts":[[2018,1,29]]},"reference":[{"key":"S0007125000121075_ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.288.6428.1399-a"},{"key":"S0007125000121075_ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1977.03280070058025"},{"key":"S0007125000121075_ref13","first-page":"359","article-title":"Hyperpyrexia in catatonic states","volume":"37","author":"Powers","year":"1976","journal-title":"The Journal of Nenous and Mental Disease"},{"key":"S0007125000121075_ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)91189-8"},{"key":"S0007125000121075_ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5803.807-c"},{"key":"S0007125000121075_ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.286.6382.1938"},{"key":"S0007125000121075_ref3","first-page":"79","article-title":"The neuroleptic malignant syndrome","volume":"41","author":"Caroff","year":"1980","journal-title":"Journal of Clinical Psychiatry"},{"key":"S0007125000121075_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(79)73727-3"},{"key":"S0007125000121075_ref1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5794.221"},{"key":"S0007125000121075_ref4","first-page":"224","article-title":"Neuroleptic malignant syndrome and malignant hyperthermia","volume":"333","author":"Caroff","year":"1983","journal-title":"Lancet"},{"key":"S0007125000121075_ref15","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1982.00340190139021"},{"key":"S0007125000121075_ref9","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.31.2.132"},{"key":"S0007125000121075_ref11","first-page":"186","article-title":"ETC in the neuroleptic malignant syndrome: case report","volume":"44","author":"Jesse","year":"1983","journal-title":"Journal of Clinical Psychiatry"},{"key":"S0007125000121075_ref12","doi-asserted-by":"publisher","DOI":"10.1007\/BF00429281"},{"key":"S0007125000121075_ref5","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1176\/ajp.139.7.944","article-title":"Treatment of neuroleptic malignant syndrome with dantrolene sodium: a case report","volume":"139","author":"Coons","year":"1982","journal-title":"American Journal of Psychiatry"},{"key":"S0007125000121075_ref10","first-page":"565","article-title":"Malignant neuroleptic syndrome\u2014its present status in Japan and clinical problems","volume":"31","author":"Itoh","year":"1977","journal-title":"Folia Psychiatrica et Neurologica Japonica"}],"container-title":["British Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0007125000121075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T23:20:43Z","timestamp":1558567243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0007125000121075\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,3]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1985,3]]}},"alternative-id":["S0007125000121075"],"URL":"https:\/\/doi.org\/10.1192\/bjp.146.3.317","relation":{},"ISSN":["0007-1250","1472-1465"],"issn-type":[{"value":"0007-1250","type":"print"},{"value":"1472-1465","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,3]]}}}